Self-assembly of cetylpyridinium chloride in water-DMF binary mixtures: a spectroscopic and physicochemical approach.

S. Mehta,S. Chaudhary,Kuldeep Kumar Bhasin

DOI: https://doi.org/10.1016/j.jcis.2008.02.043

IF: 9.9

2008-05-15

Journal of Colloid and Interface Science

Abstract:

What problem does this paper attempt to address?

The Potential Involvement of E-Cadherin and Beta-Catenins in Meningioma

Keiyu Zhou,Guangtao Wang,Yirong Wang,Hanghuang Jin,Shuxu Yang,Chibo Liu

DOI: https://doi.org/10.1371/journal.pone.0011231

IF: 3.7

2010-01-01

PLoS ONE

Abstract:OBJECTIVE: To investigate the potential involvements of E-cadherin and beta-catenin in meningioma. METHODS: Immunohistochemistry staining was performed on samples from patients with meningioma. The results were graded according to the positive ratio and intensity of tissue immunoreactivity. The expression of E-cadherin and beta-catenin in meningioma was analyzed by its relationship with WHO2007 grading, invasion, peritumoral edema and postoperative recurrence. RESULTS: The positive rates of E-cadherin in meningioma WHO I, II, III were 92.69%, 33.33% and 0, respectively, (P<0.05); while the positive rates of beta-catenin in meningioma WHO I, II, III were 82.93%, 33.33% and 20.00%, respectively, (P<0.05). The positive rate of E-cadherin in meningioma without invasion (94.12%) was higher than that with invasion (46.67%) (P<0.05). The difference in the positive rate of beta-catenin between meningioma without invasion (88.24%) and meningioma with invasion (33.33%, P<0.05) was also statically significant. The positive rates of E-cadherin in meningioma with peritumoral edema 0, 1, 2, 3 were 93.75%, 85.71%, 60.00% and 0 respectively, (P<0.05); the positive rates of beta-catenin in meningioma with peritumoral edema 0, 1, 2, 3 were 87.50%, 85.71%, 30.00% and 0 respectively, (P<0.01). The positive rates of E- cadherin in meningioma with postoperative recurrence were 33.33%, and the positive rate with postoperative non-recurrence was 90.00% (P<0.01). The positive rates of beta-catenin in meningioma with postoperative recurrence and non-recurrence were 11.11%, 85.00%, respectively (P<0.01). CONCLUSION: The expression levels of E- cadherin and beta-catenin correlated closely to the WHO 2007 grading criteria for meningioma. In atypical or malignant meningioma, the expression levels of E-cadherin and beta-catenin were significantly lower. The expression levels of E- cadherin and beta-catenin were also closely correlated with the invasion status of meningioma, the size of the peritumoral edema and the recurrent probabilities of the meningioma, all in an inverse correlationship. Taken together, the present study provided novel molecular targets in clinical treatments to meningioma.
Mast cells in meningiomas

Antonio D'Amati,Roberto Tamma,Tiziana Annese,Anna Rizzi,Domenico Ribatti

DOI: https://doi.org/10.4081/ejh.2024.3973

2024-04-18

European Journal of Histochemistry

Abstract:Meningioma represents the most frequent tumor of the central nervous system (CNS). Correlations between the presence of mast cells (MCs) and grade or other histological features of meningioma are still debated. Our study aimed to better understand the relationship between mast cells and meningiomas and to compare our results based on specific histological subtypes and novel 2021 CNS WHO grading system. We observed some differences as regards the number of MCs and meningioma grade. In low-grade (grade 1) meningiomas, MCs were observed in 7/22 cases, while they were consistently present in all eight high-grade cases (grade 2 and grade 3). Among the grade 1 meningiomas, we observed two “low-positive”, two “intermediate-positive”, and three “high-positive” cases. Among the group of high-grade meningiomas, the six cases grade 2 were considered as “low-positive”, while the two grade 3 cases showed a higher number of MCs and were included in the “intermediate-positive” group. Even though with no statistical significance, due to the low number of cases, our results seem to confirm a sort of relationship between meningioma grading and the number of MCs, as demonstrated by the higher percentage of high-grade meningiomas showing MCs infiltrates, compared to low-grade meningiomas.

cell biology
The Clinical and Histological Study of Multiple Memingiomas

KONG Jun,HUANG Hong-guang,ZHAN Ren-ya,RALF Bu-hl

DOI: https://doi.org/10.3969/j.issn.1008-8199.2006.05.020

2006-01-01

Abstract:Objective:To study the clinical and histological features of multiple meningiomas. Methods:39 cases of multiple meningiomas were analyzed retrospectively. The expressions of PR (Progesterone receptor) , p53 and MIB-1 were detected by immunohistochemistry in the samples of multiple meningiomas and solitary meningiomas. Results:Female predominance was obvious in cases of multiple meningiomas. The tumors had wide distributions with a main location in brain convexity. The results of immunohistochemistry showed stronger expression of PR and similar expression of p53 and MIB-1 in samples of multiple meningiomas than those in solitary meningiomas. Conclusion:The diagnosis of multiple meningiomas mainly depends on radiological examination. The pathogenesis of multiple meningiomas is probably related to progesterone and its receptor, and it is most likely monoclonal origin.
Expression and Biologic Significance of Vascular Endothelial Growth Factor (VEGF) in Human Meningiomas

谢尚闹,孙才兴,孙文勇,张谷

DOI: https://doi.org/10.3969/j.issn.1004-0242.2005.06.012

2005-01-01

Abstract:Purpose]To explore the expression and biologic significance of vascular endothelial growth factor (VEGF) in human meningioma.[Methods]VEGF and microvascular density(MVD) were detected in 51 cases with meningiomas(benign(grade Ⅰ),38;atypical(grade Ⅱ),11 and malignant(grade Ⅲ),2)by immunohistochemical method.[Results]Expression level of VEGF protein was not significantly different between grade Ⅰ group and grade Ⅱ,Ⅲ group. The MVD of grade Ⅰ, grade Ⅱ and Ⅲ meningioma was 131.08±115.93 and 145.12±99.21(P0.05) respectively. The expression level of VEGF was positively correlated to MVD. However, the expression level of VEGF was not correlated to tumor invasion and brain invasion. [Conclusion] VEGF may play an important role in angiogenesis and participate the development of human meningiomas. VEGF was not correlateted to the progression of meningiomas from benign status to atypical ones, tumor invasion and brain invasion.
Expression of Vascular Endothelial Growth Factor in Human Meningiomas and Peritumoral Brain Areas

Ya-Suo Ding,Han-Dong Wang,Ke Tang,Zhi-Gang Hu,Wei Jin,Wei Yan

2008-01-01

Abstract:Vascular endothelial growth factor (VEGF) is a regulator of angiogenesis, vasculogenesis, and vascular permeability. Recent reports suggest that VEGF may play a critical role in formation of peritumoral brain edema (PTBE) associated with meningiomas. While VEGF expression has been shown in meningiomas, studies have not focused on VEGF in the adjacent peritumoral brain regions. The present study examined the protein and gene expression of VEGF in human meningiomas and peritumoral brain areas. Biopsies were obtained from 37 patients. Immunohistochemical staining and immunoblotting were performed to detect the expression of VEGF protein. Reverse-transcriptase polymerase chain reaction (RTPCR) was used to analyze the presence and quantity of VEGF mRNA. The extent of PTBE was estimated as an edema index (EI) based on preoperative magnetic resonance imaging. In meningiomas, western blot and RT-PCR results were congruent and the expression of both protein and mRNA had a significant correlation with EI. However, in peritumoral areas, western blot results were not consistent with the RTPCR results. Protein results showed high correlation with EI, but mRNA was almost undetectable. In VEGF-positive cases, a decreasing gradient of VEGF protein expression was observed with increasing distance from tumors. These data suggest that peritumoral tissue does not produce VEGF and that VEGF protein levels in peritumoral tissues have a high correlation with EI. We conclude that VEGF macromolecules are secreted by the tumor tissue and enter peritumoral normal brain tissue to induce edema.
Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry

İsmail Saygin,Emel Çakir,Seher Nazlı Kazaz,Ali Rıza Güvercin,İlker Eyüpoğlu,Müşerref Müge Ustaoğlu

DOI: https://doi.org/10.55730/1300-0144.5843

2024-04-02

Abstract:Background/aim: Meningiomas are the most common primary brain tumors of the central nervous system. Immunotherapy is a promising treatment method applied in many types of cancer. There is no standard and effective medical treatment to reduce recurrence and mortality in cases of incomplete resection of meningiomas and in high-grade cases. In order to investigate medical treatments in addition to surgery and radiotherapy, in this study, the status of immune checkpoint molecules (PD-L1/PD-1), which are the target of immunotherapy, in meningiomas was investigated. Materials and methods: Four hundred two cases of meningioma diagnosed between 2007 and 2020 at our institution were used. New blocks were prepared from the appropriate blocks of the cases using the tissue microarray method. Sections obtained from these blocks were immunohistochemically stained with PD-1 and PD-L1 antibodies. Obtained data were interpreted with statistical analysis. Results: Expression of PD-L1 was observed in 28.4% of meningiomas. Staining rates are higher in high-grade tumors. The staining rate of PD-L1 in the tumor increased significantly with pattern loss. PD-L1 expression in immune cells is 19.9%. Immune cell expression and the number of expressing immune cells correlate with spontaneous necrosis. Immune cell expression and the number of expressing immune cells are increased in high-grade meningiomas. PD-1 expression in immune cells is 9.0%, and this correlates with brain invasion. Conclusions: With these data, it was observed that the expression of immune checkpoint molecules PD-L1 and PD-1 increased especially in high-grade meningiomas. It may be the subject of research that these molecules may be targets of immunotherapy in the treatment of meningiomas.
Study on Correlation of Different Levels of Meningioma and Matrix Metalloproteinase-9

Wang Xiaoning,Jiao Hongliang,Zhang Xinming,Xiao Xinguang,Zhang Xin,Li Runtao

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2017.05.049

2017-01-01

Abstract:Objective Meningioma of intracranial tumors is one of the common benign tumor of neurosurgery.The study has in contrast of the different levels of meningiomas magnetic resonance imaging (MRI) features matrix metalloproteinase (MMP)-9 expression,further study of the different meningioma MRI and molecular pathological basis.Methods 60 patients after surgical treatment had been confirmed by pathology.34 cases of meningioma grade Ⅰ,17 cases of meningiomas grade Ⅱ,9 cases of meningio mas grade Ⅲ.Using superconducting 3.0 T magnetic resonance imaging system underwent MRI plain and enhanced scan.Using of immunohistochemistry to detect meningiomas of MMP-9 expression.Results Positive expression of 34 cases of Word Health Organization (WHO) grade Ⅰ meningiomas was 8.82％,31 cases were negative,2 cases had weak expression,and 1 case had neutral expression;Positive expres sion of 17 cases of WHO grade Ⅱ meningioma was 41.00％,10 cases were negative,5 cases had weak expression,and 2 cases had neutral expression;Positive expression of 9 cases of WHO grade Ⅲ meningiomas was 100.00％,and 9 cases had strong expression.Immunohistochemistry results show:the expression of MMP-9 significant difference (x2 =68.880,P =0.001) in all levels of meningiomas.meningiomas expression of grade Ⅲ was significantly higher statistically significant than grade Ⅱ (x2 =26.000,P =0.001),meningiomas expression of grade Ⅱ was significantly higher statistically significant than grade Ⅰ (x2 =7.550,P =0.023).Lowest expression in normal meningeal tissue,meningiomas expression of grade Ⅲ of MMP-9 expression in the highest,MMP-9 protein expression levels tended to increase with menin gioma level increasing.Conclusion Meningiomas expression of grade Ⅲ is the highest in expression of MMP-9.With meningioma level increases,MMP-9 expression corresponding increase.The meningioma high expression of MMP-9 promotes peritumoral brain edema formation,with a synergistic effect on tumor proliferation and infiltration.
High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity

Maria Devetzoglou,Rodanthi Vyzoukaki,Maria Kokonozaki,Athina Xekalou,Constantina A Pappa,Anastasia Papadopoulou,Athanasios Alegakis,Nikolaos Androulakis,Michael G Alexandrakis

DOI: https://doi.org/10.1007/s13277-015-3586-9

Abstract:Multiple myeloma (MM) is a plasma cell neoplasm characterized by bone marrow infiltration from malignant plasma cells. Mast cells play an important role in inflammation and angiogenesis in malignant diseases. The aim of the study was to evaluate the mast cell density in bone marrow of untreated MM patients with markers of disease activity such as serum interleukin-6 (IL-6), B2M, and C-reactive protein (CRP), the grade of bone marrow infiltration, and the levels of produced paraprotein. We studied 86 newly diagnosed MM patients (46 males, 40 females, mean age 59 ± 13.7 years). Thirty of them reached plateau phase after chemotherapy and 20 healthy volunteers. According to the criteria of International Staging System (ISS) staging system, 23 patients had stage I, 30 had stage II, and 33 had stage III. The serum concentrations of CRP, B2M, and IL-6, and the mast cell density (MCD) values were significantly higher in MM patients' group (1.6 ± 1.8, 4.3 ± 2.9, 7.1 ± 5.1, and 9 ± 4.8), in comparison with those found in control group (0.4 ± 0.1, 1.5 ± 0.6, 1.1 ± 0.5, and 1.9 ± 0.7; p < 0.001 in all the cases). Significant differences were found between the grade of infiltration in bone marrow, and the paraprotein values in patients' serum before and after chemotherapy. Furthermore, there was a significant correlation between the MCD values and the prognostic markers CRP (r = 0.452, p < 0.0001), IL-6 (r = 0.475, p < 0.0001), bone marrow infiltration (r = 0.333, p < 0.0002), and serum paraprotein levels(r = 0.221, p < 0.04). High MCD values strengthen the hypothesis that mast cells participate in the pathogenesis of disease progression and may be used as an indicator of the disease activity.
Meningioma and Other Meningeal Tumors

Michele Bailo,Filippo Gagliardi,Nicola Boari,Alfio Spina,Martina Piloni,Antonella Castellano,Pietro Mortini

DOI: https://doi.org/10.1007/978-3-031-23705-8_3

Abstract:Meningiomas develop from meningothelial cells and approximately account for more than 30 percent of central nervous system (CNS) tumors. They can occur anywhere in the dura, most often intracranially and at dural reflection sites. Half of the cases are usually at parasagittal/falcine and convexity locations; other common sites are sphenoid ridge, suprasellar, posterior fossa, and olfactory groove. The female-to-male ratio is approximately 2 or 3-1, and the median age at diagnosis is 65 years. Meningiomas are generally extremely slow-growing tumors; many are asymptomatic or paucisymptomatic at diagnosis and are discovered incidentally. Clinical manifestations, when present, are influenced by the tumor site and by the time course over which it develops. Meningiomas are divided into three grades. Grade I represents the vast majority of cases; they are considered typical or benign, although their CNS location can still lead to severe morbidity or mortality, resulting in a reported ten-year net survival of over 80%. Atypical (WHO grade II) meningiomas are considered "intermediate grade" malignancies and represent 5-7% of cases. They show a tendency for recurrence and malignant degeneration with a relevant increase in tumor cell migration and surrounding tissue infiltration; ten-year net survival is reported over 60%. The anaplastic subtype (WHO III) represents only 1-3% of cases, and it is characterized by a poor prognosis (ten-year net survival of 15%). The treatment of choice for these tumors stands on complete microsurgical resection in case the subsequent morbidities are assumed minimal. On the other hand, and in case the tumor is located in critical regions such as the skull base, or the patient may have accompanied comorbidities, or it is aimed to avoid intensive treatment, some other approaches, including stereotactic radiosurgery and radiotherapy, were recommended as safe and effective choices to be considered as a primary treatment option or complementary to surgery. Adjuvant radiosurgery/radiotherapy should be considered in the case of atypical and anaplastic histology, especially when a residual tumor is identifiable in postoperative imaging. A "watchful waiting" strategy appears reasonable for extremely old individuals and those with substantial comorbidities or low-performance status, while there is a reduced threshold for therapeutic intervention for relatively healthy younger individuals due to the expectation that tumor progression will inevitably necessitate proactive treatment. To treat and manage meningioma efficiently, the assessments of both neurosurgeons and radiation oncologists are essential. The possibility of other rarer tumors, including hemangiopericytomas, solitary fibrous tumors, lymphomas, metastases, melanocytic tumors, and fibrous histiocytoma, must be considered when a meningeal lesion is diagnosed, especially because the ideal diagnostic and therapeutic approaches might differ significantly in every tumor type.
The cellular changes occurring with allografts of marrow-containing cortical bone.

M. Elves,J. C. Gray,P. Thorogood

1976-11-01

Journal of Anatomy

Abstract:The cell population within and around allografts of fresh, marrow-containing cortical bone has been studied. The grafts were implanted into intramuscular sites in rats and removed at intervals over a 4 week period for examination by light and electron microscopy to establish the sequence of changes at both the tissue and cellular levels. The tissue organization and the ultrastructural appearances of the cells found at different times after grafting are described; the possible relationships of the different cell types to each other and their likely roles in both the immunological and histogenic events are postulated and discussed. A comparison of the observations in the allograft and in the previously studied autograft suggests that the cells from the granulationtissue that become osteoblasts in the autograft differentiate into fibrocytes and giant cells in the allograft. Furthermore, the increased period of initial degeneration observed in the allograft (2 weeks) compared with the autograft (less than 1 week) may represent the destruction of early, graft-derived attempts at osteogenesis. This, together with the relative paucity of new bone in the allograft, suggests that some cells of graft origin may contribute to the early osteogenesis observed in the autograft.
Identification of key genes and pathways associated with resting mast cells in meningioma

Hui Xie,Ce Yuan,Xiao-hui Ding,Jin-jiang Li,Zhao-yang Li,Wei-cheng Lu

DOI: https://doi.org/10.1186/s12885-021-08931-0

IF: 4.638

2021-11-12

BMC Cancer

Abstract:Abstract Background To identify candidate key genes and pathways related to resting mast cells in meningioma and the underlying molecular mechanisms of meningioma. Methods Gene expression profiles of the used microarray datasets were obtained from the Gene Expression Omnibus (GEO) database. GO and KEGG pathway enrichments of DEGs were analyzed using the ClusterProfiler package in R. The protein-protein interaction network (PPI), and TF-miRNA- mRNA co-expression networks were constructed. Further, the difference in immune infiltration was investigated using the CIBERSORT algorithm. Results A total of 1499 DEGs were identified between tumor and normal controls. The analysis of the immune cell infiltration landscape showed that the probability of distribution of memory B cells, regulatory T cells (Tregs), and resting mast cells in tumor samples were significantly higher than those in the controls. Moreover, through WGCNA analysis, the module related to resting mast cells contained 158 DEGs, and KEGG pathway analysis revealed that the DEGs were dominant in the TNF signaling pathway, cytokine-cytokine receptor interaction, and IL-17 signaling pathway. Survival analysis of hub genes related to resting mast cells showed that the risk model was constructed based on 9 key genes. The TF-miRNA- mRNA co-regulation network, including MYC-miR-145-5p, TNFAIP3-miR-29c-3p, and TNFAIP3-hsa-miR-335-3p, were obtained. Further, 36 nodes and 197 interactions in the PPI network were identified. Conclusion The results of this study revealed candidate key genes, miRNAs, and pathways related to resting mast cells involved in meningioma development, providing potential therapeutic targets for meningioma treatment.

oncology
Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas

Antonio Ieni,Cristina Pizzimenti,Vincenzo Fiorentino,Mariausilia Franchina,Antonino Germanò,Giovanni Raffa,Maurizio Martini,Guido Fadda,Giovanni Tuccari

DOI: https://doi.org/10.1155/2024/5573892

2024-01-01

Analytical Cellular Pathology

Abstract:Among autophagic‐related proteins, p62/SQSTM1/Sequestosome‐1 represents a relevant actor in cellular proliferation and neoplastic growth. Although, recently, p62 expression has been analyzed in different neurodegenerative and glial neoplastic diseases, no available information have been reported in meningiomas, which have an high epidemiological relevance being the second most common category of intracranial tumors after gliomas. Generally meningiomas have a benign behavior, but their recurrence is not uncommon mainly when atypical or anaplastic varieties occur. However, intranuclear vacuoles have been ultrastructurally observed in meningiomas, and they were labelled by p62 antibodies. Therefore, in the present study, we have investigated p62 immunohistochemical pattern in a cohort of 133 cases representative of low‐ and high‐grade meningiomas, to verify if p62 expression may be related to clinicopathological data, thus achieving a potential prognostic role. The p62 immunoexpression was frequently found in the nucleus and cytoplasm of neoplastic elements, and utilizing an intensity‐distribution score, 55 (41.3%) cases were considered as high expressors while 78 (58.7%) cases were instead recorded as low expressors. Fifteen cases exhibited recurrences of the disease, 14 of which were codified as high expressors. Moreover, a direct relationship between p62 and Mib‐1 immunoexpression as well as between p62 and neoplastic grade have been documented. Finally, we suggest that impaired autophagic flux with an increase in p62 expression may be involved in the activation of NRF2 also contributing in the development of recurrence in meningioma patients.

oncology,pathology,cell biology
Prediction of Meningioma Grade Using Hematological Parameters

Eyup Bayatli,Onur Ozgural,Ihsan Dogan,Omer Mert Ozpiskin,Siavash Hasimoglu,Yusuf Cem Kuzukiran,Murat Zaimoglu,Umit Eroglu,Gokmen Kahilogullari,Hasan Caglar Ugur,Y Sukru Caglar,Y. Sukru Caglar

DOI: https://doi.org/10.1016/j.wneu.2024.02.148

IF: 2.21

2024-03-07

World Neurosurgery

Abstract:Structured Objective Predicting the aggressiveness of meningiomas may influence the surgical strategy timing. Because of the paucity of robust markers, the systemic immune-inflammation (SII) index is a novel biomarker to be an independent predictor of poor prognosis in various cancers including gliomas. We aimed to investigate the value of SII as well as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) indices in predicting prognosis. Methods Records including demographic, clinical, and laboratory datas of patients operated on due to intracranial meningioma in 2017–2023 were retrospectively reviewed. Results A total of 234 patients were included in this study. All of SII index, NLR and PLR values at presentation were significantly higher in grade ≥2 meningiomas. A positive correlation was observed between SII index and Ki67 index (r = 0.313; p < 0.001); between NLR and Ki67 index (r = 0.330; p < 0.001); and between PLR and Ki67 index (r = 0.223; p 618), NLR (optimal cutoff level > 3.53) and PLR (optimal cutoff level > 121.2) showed significant predictive values. Conclusions This is the first study to assess the prognostic value of the SII index in patients with intracranial meningiomas. Increased SII index, NLR and PLR were correlated with higher grade and higher Ki-67 index. They also harbor the potential to screen patients that may need more aggressive treatments or more frequent follow-up examinations.

surgery,clinical neurology
Spatial Distribution of Meningiomas: A Magnetic Resonance Image Atlas

Ruchit V Patel,Shun Yao,Efrain Aguilar Murillo,Raymond Y Huang,Wenya Linda Bi

DOI: https://doi.org/10.1227/neu.0000000000003149

IF: 5.315

2024-08-28

Neurosurgery

Abstract:Background and objectives: The size and anatomic location of meningiomas have been shown to correlate with distinct clinical manifestations, histopathological subtypes, and surgical risk. However, meningioma anatomic origin sites can be obscured in large tumors and those crossing compartments. We therefore sought to apply unbiased lesion mapping to localize intracranial meningioma distributions and their association with biology and grade. Methods: MRI scans, World Health Organization (WHO) grade, and a molecularly Integrated Grade (IG) derived from cytogenetics were analyzed from adult patients with intracranial meningiomas. Semi-automated tumor segmentation was performed on T1-weighted contrast-enhanced MRI. We used the voxel-based lesion mapping technique to generate a meningioma atlas, mapping spatial frequency and correlating with tumor grades. Results: Of 881 patients with meningioma (median age: 57 years, 68.8% female), 589 were WHO grade 1 (66.8%), 265 WHO grade 2 (30.1%), and 27 WHO grade 3 (3.1%) with a median tumor volume of 14.6 cm3. After molecular reclassification, 585 were IG-1 (66.4%), 160 IG-2 (18.2%), and 136 IG-3 (15.4%). Benign tumors were concentrated in and around the midline anterior skull base while malignant meningiomas were enriched in the falcine/parasagittal region and the sphenoid wing, similar to the distribution when stratified by chromosome 1p loss. Meningiomas exhibited sharper spatial clustering when stratified by the molecular IG than by WHO grade. WHO grade 2 meningiomas divided equally across IG 1-3, with corresponding partition of spatial distribution in the midline anterior skull base (in WHO grade 2, IG-1) and falcine/parasagittal and sphenoid regions (WHO grade 2, IG-3). Meningioma volumes significantly varied across age, sex, and WHO/IG grades. Conclusion: We demonstrate the utility of voxel-based lesion mapping for intracranial tumors, characterizing distinct meningioma distribution patterns across histopathological and molecularly defined grades. Molecular grading associated with sharper tumor spatial clusters, supporting a phenotype-genotype association in meningiomas.
Intracranial Clear Cell Meningioma: a Clinicopathologic Study of 15 Cases

Hong Chen,Xue-Min Li,Yuan-Cheng Chen,Jin-Song Wu,Ya-Fang Dou,Yin Wang,Jian Xu,Ping Zhong,Cheng-Chuan Jiang,Xiao-Qiang Wang

DOI: https://doi.org/10.1007/s00701-011-1052-z

2011-01-01

Acta Neurochirurgica

Abstract:Object Clear cell meningioma (CCM) is a rare histological variant of meningioma. CCM has a high recurrence rate and aggressiveness. In this study, we reviewed our experience in the treatment of the lesion. Methods Here we present a series of 15 patients with intracranial CCM. The clinical data were retrieved from the records of our Neurosurgery Department and the patients’ prognoses were attained by clinic service and telephone. Immunohistochemistry for epithelial membrane antigen (EMA), vimentin, glial fibrillary acidic protein (GFAP), CD10, and S-100 was done, and the MIB-1 labeling index was calculated in all cases. Results The 15 patients included eight males and seven females; the mean age was 34.8 years. The most frequent initial symptoms were headache and hearing loss. The most common location was the cerebellopontine angle (CPA) zone. Eleven patients had total removal and four patients underwent subtotal removal. Histological features of atypia were present in different proportions, from 6.7% to 100%, and six cases accorded with atypia. Three tumors showed brain invasion. EMA and vimentin were 100% positive, and CD10 was 100% negative. GFAP was 87% negative and S-100 was 93% negative. The mean follow-up period was 36.7 months. Three patients with brain invasion all recurred and five cases with atypia recurred. In 11 patients with total removal, six patients recurred. In four patients with subtotal removal, three patients recurred. Kaplan-Maier analysis showed that incomplete surgical resection was significantly associated with recurrence ( p = 0.001). The MIB-1 labeling index for recurrence was 5.7 ± 2.7% versus 2.8 ± 1.5% for no recurrence ( p = 0.036). Conclusions CCM is a rare subtype of meningioma, with a tendency to present in younger patients and a propensity to recur. Immunohistochemistry plays a vital role in differentiating CCM from other tumors. Brain invasion, atypia and MIB-1 labeling index are likely to predict the recurrence. The extent of resection might be connected with the prognosis.
Erratum: Clinical Features and Treatment of World Health Organization Grade II and III Meningiomas in Childhood: Report of 23 Cases.

Xiao-Qiang Wang,Cheng-Chuan Jiang,Lin Zhao,Ye Gong,Jie Hu,Hong Chen

DOI: https://doi.org/10.3171/2012.7.peds12179

2012-01-01

Abstract:Object High-grade meningiomas in childhood are rare, and their clinical features are unknown. The objective of this study was to determine the clinical characteristics and prognosis of childhood high-grade meningiomas. Methods Twenty-three patients with childhood high-grade meningiomas were treated at the Huashan Hospital. Clinical data were collected, tumor samples were reexamined, and prognoses were attained through follow-up visits and telephone interviews. Survival probability was calculated using the Kaplan-Meier method. A 2-sided probability level of 0.05 was chosen for statistical significance. Results The series included 18 males and 5 females (mean age 12.1 years). The most common symptoms were headache and vomiting (43%). Three patients had accompanying neurofibromatosis Type II (NF2). The high-grade meningioma cases with NF2 had larger tumor diameters than those without NF2 (p = 0.010). The skull base was the most common tumor site (39%). Complete resections were achieved in 11 patients after their initial operations. Adjuvant radiation therapy was performed in 9 cases. Follow-up evaluations were performed for 20 patients (mean follow-up 70 months). Ten patients experienced recurrences, 2 patients had lung metastases, and 7 patients died of the recurrence. The extent of surgery was significantly related to progression-free survival (PFS; p = 0.038). A negative progesterone receptor combined with strongly positive Bcl-2 immunoreactivity was significantly related to PFS (p = 0.001) and overall survival (p = 0.002). The MIB-1 labeling index was significantly related to overall survival (p = 0.018), whereas postoperative radiation therapy was not significantly related to PFS (p = 0.087) and overall survival (p = 0.40). Conclusions Childhood high-grade meningioma is a rare tumor type. Childhood high-grade meningioma has a male predominance and the basilar region is the most common tumor location. Patients with these tumors have high recurrence and mortality rates. The extent of resection is an important prognosis factor. A negative progesterone receptor combined with a strongly positive Bcl-2 immunoreaction might predict cancer recurrence. The MIB-1 labeling index correlates with the prognosis, and an MIB-1 labeling index > 3% increases the risk of recurrence in childhood high-grade meningioma. More cases should be collected, and longer follow-up periods should be obtained, to evaluate the effects of postoperative radiation therapy in childhood high-grade meningioma.
Path-28. Ki-67 Index As A Predictive Marker Of Meningioma Recurrence Following Surgical Resection

Mark Mizrachi,Benjamin Hartley,Shahzaib Saleem,Eric Hintz,Yonah Ziemba,Jianyi Li,Anuj Goenka,Michael Schulder

DOI: https://doi.org/10.1093/neuonc/noae165.0727

2024-11-29

Neuro-Oncology

Abstract:Meningiomas are the most common primary intracranial tumors in adults. Although benign in a majority of cases, they have a variable clinical course and may recur even after a thorough surgical resection. Ki-67, a nuclear protein involved in cell cycle regulation, has been widely studied as a marker of cellular proliferation in various cancers. Here, we investigate the Ki-67 index, as a predictive marker of meningioma recurrence following resection. The medical records of 451 patients with previously untreated cranial meningiomas who underwent resections from January 2011 to January 2021 at North Shore University Hospital (NSUH) were reviewed. Collected data included WHO grade, Ki-67 proliferative index, degree of resection - gross (GTR) vs subtotal (STR) - as judged by the surgeon, tumor location, and meningioma recurrence. This study was approved by the NSUH Institutional Review Board IRB 21-1107. There were 290 patients with grade I, 154 with grade II, and 7 with grade III meningiomas. Higher WHO grades were associated with higher rates of recurrence, with rates of 11.4 %, 27.9 %, and 71.4 % for grades 1, 2, and 3, respectively, and subtotal resection corresponded to a higher rate of recurrence than total resection (34.3 % and 13.4 %, respectively). Higher WHO grades also correlated with higher Ki-67 scores (2.59, 10.01, and 20.71) for grades 1, 2, and 3, respectively. A multivariate logistic regression model identified Ki-67 and degree of resection as independent predictive variables for meningioma recurrence, with Ki-67 specifically predicting recurrence in the WHO grade II subset when analyzed separately for WHO grades I and II. Our 10-year retrospective study suggests that the Ki-67 index is an important predictive marker for recurrence of intracranial meningiomas following surgical resection, particularly among patients with WHO grade II tumors. Our findings add to a growing body of data that support inclusion of Ki-67 index in the WHO grading criteria for patients with meningiomas.

oncology,clinical neurology
Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse

Yingqun Tao,Guobiao Liang,Zhiyong Li,Yunjie Wang,Anhua Wu,Hailong Wang,Yicheng Lu,Zhenyang Liu,Guohan Hu

DOI: https://doi.org/10.3109/02688697.2012.685780

2012-05-22

British Journal of Neurosurgery

Abstract:OBJECTIVE: To investigate the recurrent risk factors of intracranial meningiomas after gross-total resection (Simpson II Grade).METHODS: We retrospectively analysed 162 meningiomas in the General Hospital of Shenyang Military Region and Changzheng Hospital in Shanghai China, which underwent nearly gross-total resection using microneurosurgery techniques from 2002 to 2007. Monofactorial and Cox regression statistics methods were carried out to analyse the relationship between the post-operation tumour relapse and some clinical features including the patient sex, age, tumour size, tumour shape, tumour pathological grade and the immunohistochemical expression levels of Ki-67, androgen receptor (AR), estrogen receptor (ER) and progesterone receptor (PR).RESULTS: There are 53 recurrent meningiomas during the follow-up period. The recurrent rate is about 32.7%. Immunohistochemistry results indicate that AR, ER, PR, Ki-67 are positively expressed on some tumour cell nuclear. Cox regression analysis reveals that tumour size, tumour shape, pathological grade and Ki-67 expression levels are significantly correlated with the tumour relapse (p <0.05).CONCLUSIONS: Our results demonstrate high recurrent rate for gross-total resection meningiomas. Tumour diameter exceeding 5 cm, irregular shape tumour, pathological grade II and III and positive expression of Ki-67 were the risk factors for post-operation meningioma relapse. The recurrent rate increases coincidentally with the follow-up period.

surgery,clinical neurology
Papillary meningioma: clinical and histopathological observations.

Dai-Jun Wang,Ming-Zhe Zheng,Ye Gong,Qing Xie,Yin Wang,Hai-Xia Cheng,Ying Mao,Ping Zhong,Xiao-Ming Che,Cheng-Chuan Jiang,Feng-Ping Huang,Kang Zheng,Shi-Qi Li,Yu-Xiang Gu,Wei-Min Bao,Bo-Jie Yang,Jing-Song Wu,Li-Qian Xie,Hai-Liang Tang,Hong-Da Zhu,Xian-Cheng Chen,Liang-Fu Zhou

2013-01-01

Abstract:Papillary meningioma is a rare subtype of malignant meningiomas, which is classified by the World Health Organization as Grade III. Because of lack of large sample size case studies, many of the specific characteristics of papillary meningioma are unclear. This study investigated by retrospective analysis the clinical, radiological and histopathological findings of 17 papillary meningioma patients who underwent surgical resection or biopsy, to assess the characteristics of papillary meningioma. Eight female and nine male patients were included, with a mean age of 40 (range: 6 to 55) years. Tumors were mostly located in the cerebral convexity and showed irregular margins, absence of a peritumoral rim, heterogeneous enhancement and severe peritumoral brain edema on preoperative images. Brain invasion was often confirmed during the operations, with abundant to exceedingly abundant blood supply. Intratumoral necrosis and mitosis was frequently observed on routinely stained sections. The average MIB-1 labeling index was 6.9%. Seven cases experienced tumor recurrence or progression, while seven patients died 6 to 29 months after operation. Radiation therapy was given in 52.9% of all cases. Univariate analysis showed that only the existence of intratumoral necrosis and incomplete resection correlated with tumor recurrence. The 3-year progression free survival was 66.7% after gross total resection and 63.6% for other cases. The 3-year mortality rate was 50% after gross total resection and 63.6% for other cases. Papillary meningioma has specific clinical and histopathological characteristics. Tumor recurrence (or progression) and mortality are common. Gross total tumor resection resulted in less recurrence and mortality.

Self-assembly of cetylpyridinium chloride in water-DMF binary mixtures: a spectroscopic and physicochemical approach.

The Potential Involvement of E-Cadherin and Beta-Catenins in Meningioma

Mast cells in meningiomas

The Clinical and Histological Study of Multiple Memingiomas

Expression and Biologic Significance of Vascular Endothelial Growth Factor (VEGF) in Human Meningiomas

Expression of Vascular Endothelial Growth Factor in Human Meningiomas and Peritumoral Brain Areas

Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry

Study on Correlation of Different Levels of Meningioma and Matrix Metalloproteinase-9

High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity

Meningioma and Other Meningeal Tumors

The cellular changes occurring with allografts of marrow-containing cortical bone.

Identification of key genes and pathways associated with resting mast cells in meningioma

Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas

Prediction of Meningioma Grade Using Hematological Parameters

Spatial Distribution of Meningiomas: A Magnetic Resonance Image Atlas

Intracranial Clear Cell Meningioma: a Clinicopathologic Study of 15 Cases

Erratum: Clinical Features and Treatment of World Health Organization Grade II and III Meningiomas in Childhood: Report of 23 Cases.

Path-28. Ki-67 Index As A Predictive Marker Of Meningioma Recurrence Following Surgical Resection

Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse

Papillary meningioma: clinical and histopathological observations.